{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:16:25Z","timestamp":1783494985201,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07378-y","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:54:53Z","timestamp":1783493693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retinal sublayer changes in cases with Alzheimer\u2019s disease and depression"],"prefix":"10.1007","author":[{"given":"Mohammad Reza","family":"Talebnejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Zia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid Reza","family":"Ostovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Nazarpour-Servak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hossein","family":"Nowroozzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"7378_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A, Ekavali (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67:195\u2013203. https:\/\/doi.org\/10.1016\/j.pharep.2014.09.004","journal-title":"Pharmacol Rep"},{"key":"7378_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2018.07.216","volume":"15","author":"KB Rajan","year":"2019","unstructured":"Rajan KB et al (2019) Prevalence and incidence of clinically diagnosed Alzheimer\u2019s disease dementia from 1994 to 2012 in a population study. Alzheimers Dement 15:1\u20137. https:\/\/doi.org\/10.1016\/j.jalz.2018.07.216","journal-title":"Alzheimers Dement"},{"key":"7378_CR3","first-page":"2133","volume":"48","author":"E Navipour","year":"2019","unstructured":"Navipour E et al (2019) Epidemiology and risk factors of Alzheimer\u2019s disease in Iran: a systematic review. Iran J Public Health 48:2133\u20132139","journal-title":"Iran J Public Health"},{"key":"7378_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jamainternmed.2015.2152","volume":"175","author":"KK Tsoi","year":"2015","unstructured":"Tsoi KK et al (2015) Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med 175:1450\u20131458. https:\/\/doi.org\/10.1001\/jamainternmed.2015.2152","journal-title":"JAMA Intern Med"},{"key":"7378_CR5","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88:640\u2013651. https:\/\/doi.org\/10.1016\/j.bcp.2013.12.024","journal-title":"Biochem Pharmacol"},{"key":"7378_CR6","doi-asserted-by":"publisher","unstructured":"Weller J, Budson A (2018) Current understanding of Alzheimer\u2019s disease diagnosis and treatment. https:\/\/doi.org\/10.12688\/f1000research.14506.1. F1000Res 7","DOI":"10.12688\/f1000research.14506.1"},{"key":"7378_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40120-019-00148-5","volume":"8","author":"AD Burke","year":"2019","unstructured":"Burke AD et al (2019) Diagnosing and treating depression in patients with Alzheimer\u2019s disease. Neurol Ther 8:325\u2013350. https:\/\/doi.org\/10.1007\/s40120-019-00148-5","journal-title":"Neurol Ther"},{"key":"7378_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/13651500802684500","volume":"13","author":"P Hancock","year":"2009","unstructured":"Hancock P, Larner AJ (2009) Clinical utility of Patient Health Questionnaire-9 (PHQ-9) in memory clinics. Int J Psychiatry Clin Pract 13:188\u2013191. https:\/\/doi.org\/10.1080\/13651500802684500","journal-title":"Int J Psychiatry Clin Pract"},{"key":"7378_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-021-00230-9","volume":"10","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer\u2019s disease. Transl Neurodegener 10:6. https:\/\/doi.org\/10.1186\/s40035-021-00230-9","journal-title":"Transl Neurodegener"},{"key":"7378_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaophthalmol.2021.0320","volume":"139","author":"MS Byun","year":"2021","unstructured":"Byun MS et al (2021) Association of retinal changes with Alzheimer disease neuroimaging biomarkers in cognitively normal individuals. JAMA Ophthalmol 139:548\u2013556","journal-title":"JAMA Ophthalmol"},{"key":"7378_CR11","unstructured":"De Guia IL (2022) Retinal imaging for the early diagnosis of Alzheimer\u2019s disease. Dissertation, Macquarie University"},{"key":"7378_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2478\/jtim-2021-0053","volume":"10","author":"X Ma","year":"2022","unstructured":"Ma X et al (2022) Retinal examination modalities in the early detection of Alzheimer\u2019s disease: seeing brain through the eye. J Transl Intern Med 10:185\u2013187","journal-title":"J Transl Intern Med"},{"key":"7378_CR13","doi-asserted-by":"publisher","first-page":"e107553","DOI":"10.1371\/journal.pone.0107553","volume":"9","author":"K Hirasawa","year":"2014","unstructured":"Hirasawa K et al (2014) Determination of axial length requiring adjustment of measured circumpapillary retinal nerve fiber layer thickness for ocular magnification. PLoS ONE 9:e107553. https:\/\/doi.org\/10.1371\/journal.pone.0107553","journal-title":"PLoS ONE"},{"key":"7378_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00417-014-2915-9","volume":"253","author":"I Ctori","year":"2015","unstructured":"Ctori I, Gruppetta S, Huntjens B (2015) The effects of ocular magnification on Spectralis spectral domain optical coherence tomography scan length. Graefes Arch Clin Exp Ophthalmol 253:733\u2013738. https:\/\/doi.org\/10.1007\/s00417-014-2915-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7378_CR15","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1167\/iovs.13-12046","volume":"54","author":"E Marziani","year":"2013","unstructured":"Marziani E et al (2013) Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer\u2019s disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54:5953\u20135958. https:\/\/doi.org\/10.1167\/iovs.13-12046","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7378_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/aian.AIAN_368_17","volume":"21","author":"C Poroy","year":"2018","unstructured":"Poroy C, Y\u00fccel A\u00c2 (2018) Optical coherence tomography: is really a new biomarker for Alzheimer\u2019s disease? Ann Indian Acad Neurol 21:119\u2013125. https:\/\/doi.org\/10.4103\/aian.AIAN_368_17","journal-title":"Ann Indian Acad Neurol"},{"key":"7378_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"7378_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.archger.2014.10.011","volume":"60","author":"L Gao","year":"2015","unstructured":"Gao L et al (2015) Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer\u2019s disease. Arch Gerontol Geriatr 60:162\u2013167. https:\/\/doi.org\/10.1016\/j.archger.2014.10.011","journal-title":"Arch Gerontol Geriatr"},{"key":"7378_CR19","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1167\/iovs.06-1029","volume":"48","author":"F Berisha","year":"2007","unstructured":"Berisha F et al (2007) Retinal abnormalities in early Alzheimer\u2019s disease. Invest Ophthalmol Vis Sci 48:2285\u20132289. https:\/\/doi.org\/10.1167\/iovs.06-1029","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7378_CR20","first-page":"134","volume":"46","author":"Y Chi","year":"2010","unstructured":"Chi Y, Wang YH, Yang L (2010) The investigation of retinal nerve fiber loss in Alzheimer\u2019s disease. Zhonghua Yan Ke Za Zhi 46:134\u2013139","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"7378_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e318267fd5f","volume":"33","author":"S Kirbas","year":"2013","unstructured":"Kirbas S et al (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33:58\u201361. https:\/\/doi.org\/10.1097\/WNO.0b013e318267fd5f","journal-title":"J Neuroophthalmol"},{"key":"7378_CR22","doi-asserted-by":"publisher","unstructured":"Koronyo-Hamaoui M et al (2011) Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54 Suppl 1S204\u2013S217. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020","DOI":"10.1016\/j.neuroimage.2010.06.020"},{"key":"7378_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10072-014-2055-3","volume":"36","author":"EO Oktem","year":"2015","unstructured":"Oktem EO et al (2015) The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci 36:1141\u20131146. https:\/\/doi.org\/10.1007\/s10072-014-2055-3","journal-title":"Neurol Sci"},{"key":"7378_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/wno.0000000000000831","volume":"40","author":"V Cipollini","year":"2020","unstructured":"Cipollini V et al (2020) Neurocognitive assessment and retinal thickness alterations in Alzheimer disease: is there a correlation? J Neuroophthalmol 40:370\u2013377. https:\/\/doi.org\/10.1097\/wno.0000000000000831","journal-title":"J Neuroophthalmol"},{"key":"7378_CR25","first-page":"687","volume":"145","author":"I Lancu","year":"2006","unstructured":"Lancu I, Olmer A (2006) The mini-mental state examination: an up-to-date review. Harefuah 145:687\u2013690","journal-title":"Harefuah"},{"key":"7378_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.neulet.2016.07.006","volume":"629","author":"A Trebbastoni","year":"2016","unstructured":"Trebbastoni A et al (2016) Retinal nerve fibre layer thickness changes in Alzheimer\u2019s disease: results from a 12-month prospective case series. Neurosci Lett 629:165\u2013170. https:\/\/doi.org\/10.1016\/j.neulet.2016.07.006","journal-title":"Neurosci Lett"},{"key":"7378_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","volume":"6","author":"J den Haan","year":"2017","unstructured":"den Haan J et al (2017) Retinal thickness in Alzheimer\u2019s disease: a systematic review and meta-analysis. Alzheimers Dement (Amst) 6:162\u2013170. https:\/\/doi.org\/10.1016\/j.dadm.2016.12.014","journal-title":"Alzheimers Dement (Amst)"},{"key":"7378_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/alz.12006","volume":"16","author":"J Alber","year":"2020","unstructured":"Alber J et al (2020) Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: what we know, what we don\u2019t, and how to move forward. Alzheimers Dement 16:229\u2013243. https:\/\/doi.org\/10.1002\/alz.12006","journal-title":"Alzheimers Dement"},{"key":"7378_CR29","doi-asserted-by":"publisher","first-page":"e0153830","DOI":"10.1371\/journal.pone.0153830","volume":"11","author":"LP Cunha","year":"2016","unstructured":"Cunha LP et al (2016) Macular thickness measurements with frequency domain-OCT for quantification of retinal neural loss and its correlation with cognitive impairment in Alzheimer\u2019s disease. PLoS ONE 11:e0153830","journal-title":"PLoS ONE"},{"key":"7378_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.32598\/bcn.2021.2040.1","volume":"13","author":"Z Farzinvash","year":"2022","unstructured":"Farzinvash Z et al (2022) Retinal ganglion cell complex in Alzheimer disease: comparing ganglion cell complex and central macular thickness in Alzheimer disease and healthy subjects using spectral domain-optical coherence tomography. Basic Clin Neurosci 13:675\u2013684. https:\/\/doi.org\/10.32598\/bcn.2021.2040.1","journal-title":"Basic Clin Neurosci"},{"key":"7378_CR31","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1167\/iovs.13-12046","volume":"54","author":"E Marziani","year":"2013","unstructured":"Marziani E et al (2013) Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer\u2019s disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54:5953\u20135958","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7378_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/ceo.12386","volume":"43","author":"HA Bayhan","year":"2015","unstructured":"Bayhan HA et al (2015) Evaluation of the chorioretinal thickness changes in Alzheimer\u2019s disease using spectral-domain optical coherence tomography. Clin Exp Ophthalmol 43:145\u2013151","journal-title":"Clin Exp Ophthalmol"},{"key":"7378_CR33","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1111\/aos.12977","volume":"94","author":"E Garcia-Martin","year":"2016","unstructured":"Garcia-Martin E et al (2016) Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer\u2019s disease. Acta Ophthalmol 94:e454\u2013e459","journal-title":"Acta Ophthalmol"},{"key":"7378_CR34","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fnins.2020.00758","volume":"14","author":"S Lee","year":"2020","unstructured":"Lee S et al (2020) Amyloid beta immunoreactivity in the retinal ganglion cell layer of the Alzheimer\u2019s eye. Front Neurosci 14:758. https:\/\/doi.org\/10.3389\/fnins.2020.00758","journal-title":"Front Neurosci"},{"key":"7378_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/mp.2016.251","volume":"22","author":"T Shah","year":"2017","unstructured":"Shah T et al (2017) Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer\u2019s disease. Mol Psychiatry 22:353\u2013363","journal-title":"Mol Psychiatry"},{"key":"7378_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/alz.12006","volume":"16","author":"J Alber","year":"2020","unstructured":"Alber J et al (2020) Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: what we know, what we don\u2019t, and how to move forward. Alzheimers Dement 16:229\u2013243","journal-title":"Alzheimers Dement"},{"key":"7378_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2023.01.015","volume":"125","author":"BJ Kim","year":"2023","unstructured":"Kim BJ et al (2023) Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer\u2019s disease. Neurobiol Aging 125:74\u201382. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.01.015","journal-title":"Neurobiol Aging"},{"key":"7378_CR38","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3390\/jcm9061951","volume":"9","author":"KI Jung","year":"2020","unstructured":"Jung KI et al (2020) Attenuated visual function in patients with major depressive disorder. J Clin Med 9:1951. https:\/\/doi.org\/10.3390\/jcm9061951","journal-title":"J Clin Med"},{"key":"7378_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5152\/npa.2015.10115","volume":"54","author":"\u0130 S\u00f6nmez","year":"2017","unstructured":"S\u00f6nmez \u0130, K\u00f6\u015fger F, Aykan \u00dc (2017) Retinal nerve fiber layer thickness measurement by spectral-domain optical coherence tomography in patients with major depressive disorder. Noro Psikiyatr Ars 54:62\u201366. https:\/\/doi.org\/10.5152\/npa.2015.10115","journal-title":"Noro Psikiyatr Ars"},{"key":"7378_CR40","doi-asserted-by":"publisher","first-page":"e2134753","DOI":"10.1001\/jamanetworkopen.2021.34753","volume":"4","author":"FCT van der Heide","year":"2021","unstructured":"van der Heide FCT et al (2021) Association of retinal nerve fiber layer thickness, an index of neurodegeneration, with depressive symptoms over time. JAMA Netw Open 4:e2134753. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.34753","journal-title":"JAMA Netw Open"},{"key":"7378_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jad.2016.06.039","volume":"204","author":"A Kalenderoglu","year":"2016","unstructured":"Kalenderoglu A et al (2016) Optic coherence tomography shows inflammation and degeneration in major depressive disorder patients correlated with disease severity. J Affect Disord 204:159\u2013165. https:\/\/doi.org\/10.1016\/j.jad.2016.06.039","journal-title":"J Affect Disord"},{"key":"7378_CR42","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/gps.5556","volume":"36","author":"DKY Leung","year":"2021","unstructured":"Leung DKY et al (2021) Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta-analysis. Int J Geriatr Psychiatry 36:1330\u20131344. https:\/\/doi.org\/10.1002\/gps.5556","journal-title":"Int J Geriatr Psychiatry"},{"key":"7378_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/s1041610220001118","volume":"35","author":"JD Collins","year":"2023","unstructured":"Collins JD, Henley SMD, Su\u00e1rez-Gonz\u00e1lez A (2023) A systematic review of the prevalence of depression, anxiety, and apathy in frontotemporal dementia, atypical and young-onset Alzheimer\u2019s disease, and inherited dementia. Int Psychogeriatr 35:457\u2013476. https:\/\/doi.org\/10.1017\/s1041610220001118","journal-title":"Int Psychogeriatr"},{"key":"7378_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41398-020-0839-1","volume":"10","author":"FS Dafsari","year":"2020","unstructured":"Dafsari FS, Jessen F (2020) Depression: an underrecognized target for prevention of dementia in Alzheimer\u2019s disease. Transl Psychiatry 10:160. https:\/\/doi.org\/10.1038\/s41398-020-0839-1","journal-title":"Transl Psychiatry"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07378-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:54:57Z","timestamp":1783493697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07378-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":44,"alternative-id":["7378"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07378-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethic Committee of Shiraz University of Medical University Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}},{"value":"Written informed consent was obtained from all participants or their legally authorized representatives prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}